Security Snapshot

NEW YORK LIFE INVESTMENTS ET - NYLI FTSE INTERN (HFXI) Institutional Ownership

CUSIP: 45409B560

13F Institutional Holders and Ownership History from Q3 2015 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

99

Shares (Excl. Options)

31,690,948

Price

$33.58

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+3,211,791
Value change
+$107,735,849
Number of holders
99
Issuer context Names, identifiers, and filing context for this profile. 1 identity field
SEC-reported price per share
$37.05
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • HFXI - NEW YORK LIFE INVESTMENTS ET - NYLI FTSE INTERN is tracked under CUSIP 45409B560.
  • 99 institutions reported positions in Q1 2026.
  • Schedule 13D/13G significant owner rows are not currently available.

Change

  • Holder count moved from 89 to 99 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $923,293,720 to $1,063,593,435.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 99 institutions filings for Q1 2026.

Open SEC evidence

Security key

45409B560

Latest holder period

Q1 2026

13F holders

99

13D/G owners

0

CIK / CUSIP context first

As of 31 Mar 2026, 99 institutional investors reported holding 31,690,948 shares of NEW YORK LIFE INVESTMENTS ET - NYLI FTSE INTERN (HFXI).

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
43
Latest
Q1 2026
Rows shown
1-25 of 43
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 31,690,948 $1,063,593,435 +$107,735,849 $33.58 99
2025 Q4 28,431,351 $923,293,720 +$30,376,061 $32.45 89
2025 Q3 27,457,140 $851,670,372 +$6,739,428 $31.01 80
2025 Q2 26,750,690 $788,444,661 -$47,372,253 $29.47 80
2025 Q1 28,561,319 $786,070,487 +$122,540,125 $27.52 79
2024 Q4 25,675,549 $671,379,185 +$54,196,434 $26.06 74
2024 Q3 23,085,359 $636,509,940 +$143,821,476 $27.64 68
2024 Q2 18,000,361 $481,076,773 +$20,514,436 $26.70 67
2024 Q1 17,006,586 $456,208,352 +$23,244,404 $26.83 60
2023 Q4 16,152,226 $401,694,395 +$31,890,583 $24.87 57
2023 Q3 14,607,188 $337,996,972 +$42,880,700 $23.14 44
2023 Q2 12,879,982 $308,651,604 +$28,481,711 $23.96 43
2023 Q1 11,698,046 $269,870,888 +$2,432,506 $23.07 34
2022 Q4 11,541,196 $246,407,208 +$35,925,434 $21.35 32
2022 Q3 9,846,147 $189,724,000 +$6,253,948 $19.27 32
2022 Q2 9,497,217 $198,310,000 -$24,185,818 $20.88 33
2022 Q1 10,638,311 $250,991,000 -$12,681,878 $23.60 35
2021 Q4 11,131,755 $278,852,000 -$4,886,562 $25.05 34
2021 Q3 11,327,386 $276,735,240 +$4,223,105 $24.43 37
2021 Q2 11,156,130 $276,323,000 -$806,984 $24.77 30
2021 Q1 11,194,885 $267,555,000 -$5,597,018 $23.90 30
2020 Q4 11,416,347 $258,956,000 -$7,618,599 $22.68 30
2020 Q3 11,752,833 $233,772,000 +$4,833,875 $19.89 27
2020 Q2 11,499,288 $222,585,000 -$29,098,365 $19.36 31
2020 Q1 13,072,121 $219,652,000 +$38,570,181 $16.80 34
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .